Fundz

Qkine Raises Over £4M To Scale Manufacturing, R&D And Commercial Functions

PRIVATEDec 15, 2022

Amount Raised

£4 Million

Round Type

Seed

CambridgeManufacturingBiotechnology

Investors

Downing Ventures

Description

Qkine Ltd, a manufacturer of animal-free, highly bioactive, and innovative proteins and growth factors for life science applications, announces the close of its oversubscribed funding raise, having secured £4.3M. The round, which was co-led by Parkwalk Advisors Ltd and Downing Ventures, attracted support from existing and new leading life science funds and angel investors. The investment will enable substantial scaling of manufacturing, R&D and commercial functions.

Quick answer

Qkine raised £4 Million in a Seed round, dated December 15, 2022. Investors: Downing Ventures. Qkine is based in Cambridge, Maryland, United States.

How much did Qkine raise?
Qkine raised £4 Million in a Seed round on December 15, 2022.
Who invested in Qkine?
Downing Ventures is named as investors in this round.
What does Qkine do?
Qkine manufactures high-quality and novel growth factors, supporting scientists in developing and scaling stem cell, organoid, cellular agriculture and regenerative medicine applications.
Where is Qkine based and how big is it?
Qkine is based in Cambridge, Maryland, United States.

Source: Fundz verified event record.

Who else raised in Manufacturing and Biotechnology around the same time

Companies in the same sectors as Qkine that raised within 45 days of this round, from Fundz verified event records.

  • Enzene raised $50M (Funding Round) on January 29, 2023.
  • Renaissance Fusion raised $16M (Funding Round) on January 26, 2023.
  • iVexSol raised $24M (Series A) on January 26, 2023.
  • Membrion raised an undisclosed amount (Funding Round) on January 20, 2023.
  • Arkeon raised an undisclosed amount (Funding Round) on January 19, 2023.
  • BioProtonics raised $109K (Seed) on January 18, 2023.

Who to call at Qkine, and when

A new round usually means Qkine is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Qkine raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Qkine, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Qkine. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Qkine

Location

Cambridge Science Park

Cambridge, Maryland, United States

About

Qkine manufactures high-quality and novel growth factors, supporting scientists in developing and scaling stem cell, organoid, cellular agriculture and regenerative medicine applications. We are also developing new growth factor technologies to enable emerging fields such as cultured meat and 3D cell culture. All Qkine high purity animal-free growth factor proteins are manufactured at our facility in Cambridge, UK . Extensive quality testing is conducted on every lot to guarantee reproducibility. Based on proprietary technology developed in the laboratory of Dr Marko Hyvönen, senior group leader at the University of Cambridge, Qkine manufactures highly pure bioactive recombinant proteins. Along with setting a new benchmark for protein purity, Qkine uses protein engineering techniques to tackle fundamental biological and scalability challenges that are holding back the stem cell and regenerative medicine sector; for example, recent projects have included development of optimised R-spondins to replace conditioned media for organoid culture. To give stem cell scientists peace of mind, Qkine manufactures its proteins in a dedicated animal-derived component-free (ADCF) laboratory under an ISO 9001:2015. We define rigorous quality criteria, with detailed data. Bulk orders and stock reservations are available. For more information please visit www.qkine.com, or contact the Qkine Team at info@qkine.com

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Qkine raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Qkine's next move

See what Strategic adds

Qkine raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.